Dr. Herman Weiss
Oct 7, 2026
If you have PMOS (the condition formerly known as PCOS) and you have been through fertility treatment, there is a good chance someone handed you metformin along the way. The idea made sense on paper: metformin improves insulin resistance, insulin resistance sits at the heart of PMOS, so maybe metformin before IVF would improve ovulation and pregnancy rates. Doctors have prescribed it for this purpose for years.
This week we got the largest real-world answer so far, and it is a clear one.
The research. Cho, Park, Lee, Lim, Shin, and Kwak used South Korea's national health insurance database to study 10,178 women with PMOS who underwent their first fresh embryo transfer between 2017 and 2021. About one in five (2,149 women, 21.1%) had received metformin for ovulation induction in the 12 weeks before their ovarian stimulation. The team then compared outcomes between women who took metformin and women who did not, using a statistical weighting method to make the two groups as comparable as possible.
The result: metformin made no meaningful difference. Rates of successful egg retrieval (risk ratio 1.01), clinical pregnancy (risk ratio 1.05), and live birth (risk ratio 1.05, with a confidence interval of 0.99 to 1.12 that crosses the line of no effect) were essentially the same whether or not a woman took metformin. Just as important, there was no sign of harm: miscarriage (risk ratio 1.01) and preterm birth (risk ratio 0.99) were no different either.
Three subgroups showed a hint of possible benefit - women aged 35 and older, women on a specific stimulation protocol (the GnRH antagonist protocol), and women who took metformin for 30 days or more. These are signals to study further, not answers.
The plain-English meaning. For the average woman with PMOS heading into IVF, taking metformin beforehand does not raise the odds of bringing home a baby - and it does not lower them either. A very common, well-intentioned add-on turns out to be neutral for this particular job. That is valuable knowledge. It means one less pill to swallow for a purpose it does not serve, and it frees the conversation with your doctor to focus on what actually does move the needle.
What this does NOT mean. Metformin still has a real role in PMOS - as a metabolic medication, for insulin resistance and blood-sugar control, when your doctor judges you need it. This study asked a narrow question (does it help IVF succeed?) and answered that one. It was not testing metformin's metabolic uses.
And for the menopause half of our community, this is worth reading too. PMOS is a lifelong metabolic condition, and the same drug many of these women took hoping for a baby is the one whose real value is protecting their metabolic health for the decades that come after - including the transition into perimenopause, when insulin resistance tends to climb again. Getting clear on what each treatment is actually for, at each stage, is exactly the handoff this community is built on. And to our menopause readers: about one in eight women has PMOS. When you see how carefully this question was answered for them, expect the same standard of evidence for your own care.
The honest caveats. This is an observational study using insurance records, not a randomized trial. Women who were prescribed metformin probably differed from those who were not - often the ones with more obvious insulin resistance - and the researchers' statistical adjustments can only partly correct for that. The data come from one country's health system, cover only first fresh embryo transfers, and cannot tell us about dose or how faithfully women took the medication. The subgroup findings (age 35 and up, antagonist protocol, longer use) are hypothesis-generating at best; they need a proper trial. And full transparency: the journal page itself was not directly reachable this week, so this report is based on the published abstract and indexing records (doi:10.1002/cpt.70512, PMID 42827289).
What you gain from this. If you have PMOS and IVF is in your present or your future: do not start metformin expecting it to improve your chances - the best nationwide data says it does not. Do not stop it on your own either, especially if it was prescribed for insulin resistance or blood sugar; that is a different job, and this study says nothing against it. Bring the question to your doctor: "What am I taking this for?" If you are 35 or older, or on an antagonist protocol, ask whether the subgroup signal applies to you. And whatever stage you are at - trying to conceive, raising teenagers, or approaching the transition - the principle holds: every medication should have a job description, and you deserve to know what it is.
I read the science so you don't have to.
Dr. Herman Weiss
Medical Disclaimer
The information provided in this blog post and newsletter is for educational and informational purposes only. It does not constitute medical advice or professional services and should not be used to diagnose or treat any health problem or disease. Always seek the advice of your physician or other qualified health-care provider regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read here. Use of this content does not create a doctor-patient relationship. Individual responses to treatments and lifestyle changes can vary, and only your healthcare provider can evaluate your specific circumstances. If you are experiencing a medical emergency, call your local emergency services immediately.